GlaxoSmithKline to acquire Aiolos for up to $1.4 billion
我放心你带套猛
发表于 2024-1-9 16:39:32
288
0
0
Caixin News Agency, January 9th - GlaxoSmithKline announced on January 9th that it will acquire Aiolos Bio for a prepayment of $1 billion and a milestone payment of up to $400 million. Through the acquisition, GlaxoSmithKline has acquired Aiolos AIO-001.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
转播
You may like
- Eating all the AI dividends, has Nvidia reached its end? Many hedge funds have started profit taking models
- The potential total transaction amount can reach up to $8.4 billion! Baili Tianheng and Baishi Meishi Squibb have reached a cooperation agreement
- Top 20 US stock trading volume: Apple will abandon its 10-year electric vehicle development plan and shift towards generative artificial intelligence
- AstraZeneca acquires pharmaceutical company Amolyt Pharm for up to $1.05 billion
- How many bulls are there in the US stock market? Bank of America predicts: another 34% increase within two years, at least by 2030!
